By Will Dunham WASHINGTON, June 25 (Reuters) - A biotech company and a U.S. government agency announced on Thursday a plan to ...
Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...
At its latest R&D update, Moderna revealed a move into the pioneering in vivo CAR-T category, adding another treatment class ...
A probiotic strain developed by Korean researchers with government R&D funding to help relieve menopause symptoms has entered ...
Biopharmaceutical company Pangen, led by CEO Yoon Jae-seung, is developing three blockbuster-class biosimilars and plans to complete their production processes ...
Circular Bio-based Europe Joint Undertaking spune că IMM-urile au devenit actori centrali în transformarea inovației ...
Feeling drained? Vitamin B12 deficiency can hide behind fatigue. Discover the symptoms and food sources to reclaim your ...
The move comes as the Trump administration is trying to weaken the act that’s meant to protect endangered species from going extinct in the first place.
When Jasmin Imran Alsous peered down her microscope lens, she expected to see chaos—a mishmash of tangled cells. She was viewing the inside of a male fruit fly's sperm storage organ, using a powerful ...
There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...
Among the central risk factors in early-stage oncology investing is the distance separating laboratory findings from clinical reality. Onco-Innovations has worked methodically to close that gap. The ...
The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results